Immune Checkpoint Blockade for Advanced NSCLC: A New Landscape for Elderly Patients

The therapeutic scenario for elderly patients with advanced NSCLC has been limited to radiotherapy and chemotherapy. Recently, a novel therapeutic approach based on targeting the immune-checkpoints has showed noteworthy results in advanced NSCLC. PD1/PD-L1 pathway is co-opted by tumor cells through...

Descripción completa

Detalles Bibliográficos
Autores principales: Perrotta, Fabio, Rocco, Danilo, Vitiello, Fabiana, De Palma, Raffaele, Guerra, Germano, De Luca, Antonio, Navani, Neal, Bianco, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539213/
https://www.ncbi.nlm.nih.gov/pubmed/31067796
http://dx.doi.org/10.3390/ijms20092258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539213/
https://www.ncbi.nlm.nih.gov/pubmed/31067796
http://dx.doi.org/10.3390/ijms20092258

Ejemplares similares